
PentaMedix provides cancer patients with AI-driven research insights to support understanding of their condition and treatment options. The platform applies machine learning and artificial intelligence models to biomedical and clinical research data to generate those insights. It operates as a research-focused healthcare platform (B2C) that combines AI technology with patient-facing research tools. PentaMedix targets the oncology space, aiming to make research-grade analyses accessible to patients and interested caregivers.

PentaMedix provides cancer patients with AI-driven research insights to support understanding of their condition and treatment options. The platform applies machine learning and artificial intelligence models to biomedical and clinical research data to generate those insights. It operates as a research-focused healthcare platform (B2C) that combines AI technology with patient-facing research tools. PentaMedix targets the oncology space, aiming to make research-grade analyses accessible to patients and interested caregivers.